146 related articles for article (PubMed ID: 10848781)
21. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants.
Carretero M; Palmieri G; Llano M; Tullio V; Santoni A; Geraghty DE; López-Botet M
Eur J Immunol; 1998 Apr; 28(4):1280-91. PubMed ID: 9565368
[TBL] [Abstract][Full Text] [Related]
22. CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.
Zingoni A; Palmieri G; Morrone S; Carretero M; Lopez-Botel M; Piccoli M; Frati L; Santoni A
Eur J Immunol; 2000 Feb; 30(2):644-51. PubMed ID: 10671222
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes.
Bertone S; Schiavetti F; Bellomo R; Vitale C; Ponte M; Moretta L; Mingari MC
Eur J Immunol; 1999 Jan; 29(1):23-9. PubMed ID: 9933082
[TBL] [Abstract][Full Text] [Related]
24. CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells.
Palmieri G; Tullio V; Zingoni A; Piccoli M; Frati L; Lopez-Botet M; Santoni A
J Immunol; 1999 Jun; 162(12):7181-8. PubMed ID: 10358164
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors.
Bigouret V; Hoffmann T; Arlettaz L; Villard J; Colonna M; Ticheli A; Gratwohl A; Samii K; Chapuis B; Rufer N; Roosnek E
Blood; 2003 Apr; 101(8):3198-204. PubMed ID: 12480700
[TBL] [Abstract][Full Text] [Related]
26. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240
[TBL] [Abstract][Full Text] [Related]
27. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules.
López-Botet M; Pérez-Villar JJ; Carretero M; Rodríguez A; Melero I; Bellón T; Llano M; Navarro F
Immunol Rev; 1997 Feb; 155():165-74. PubMed ID: 9059892
[TBL] [Abstract][Full Text] [Related]
28. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG
J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992
[TBL] [Abstract][Full Text] [Related]
29. Human T cell receptor-mediated recognition of HLA-E.
García P; Llano M; de Heredia AB; Willberg CB; Caparrós E; Aparicio P; Braud VM; López-Botet M
Eur J Immunol; 2002 Apr; 32(4):936-44. PubMed ID: 11920559
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
31. Persistent expression of CD94/NKG2 receptors by virus-specific CD8 T cells is initiated by TCR-mediated signals.
Wojtasiak M; Jones CM; Sullivan LC; Winterhalter AC; Carbone FR; Brooks AG
Int Immunol; 2004 Sep; 16(9):1333-41. PubMed ID: 15302848
[TBL] [Abstract][Full Text] [Related]
32. Preferential survival of CD8 T and NK cells expressing high levels of CD94.
Gunturi A; Berg RE; Forman J
J Immunol; 2003 Feb; 170(4):1737-45. PubMed ID: 12574337
[TBL] [Abstract][Full Text] [Related]
33. Expression of NK cell receptors on decidual T cells in human pregnancy.
Tilburgs T; van der Mast BJ; Nagtzaam NM; Roelen DL; Scherjon SA; Claas FH
J Reprod Immunol; 2009 Jun; 80(1-2):22-32. PubMed ID: 19394706
[TBL] [Abstract][Full Text] [Related]
34. Role for NKG2-A and NKG2-C surface receptors in chronic CD4+ T-cell responses.
Ortega C; Romero P; Palma A; Orta T; Peña J; García-Vinuesa A; Molina IJ; Santamaría M
Immunol Cell Biol; 2004 Dec; 82(6):587-95. PubMed ID: 15550116
[TBL] [Abstract][Full Text] [Related]
35. Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cells.
Young NT; Rust NA; Dallman MJ; Cerundolo V; Morris PJ; Welsh KI
Hum Immunol; 1998 Nov; 59(11):700-12. PubMed ID: 9796738
[TBL] [Abstract][Full Text] [Related]
36. Renal carcinoma cell lines inhibit natural killer activity via the CD94 receptor molecule.
Stanley AJ; Gough MJ; Banks RE; Selby PJ; Patel PM
Cancer Immunol Immunother; 2001 Jul; 50(5):260-8. PubMed ID: 11499809
[TBL] [Abstract][Full Text] [Related]
37. Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2A class I receptor on CD94- peripheral Vgamma9 Vdelta2 T cells but not on CD94- thymic or mature gammadelta T cell clones.
Boullier S; Poquet Y; Halary F; Bonneville M; Fournie JJ; Gougeon ML
Eur J Immunol; 1998 Nov; 28(11):3399-410. PubMed ID: 9842883
[TBL] [Abstract][Full Text] [Related]
38. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
[TBL] [Abstract][Full Text] [Related]
39. Pure red cell aplasia associated with expansion of CD3+ CD8+ granular lymphocytes expressing cytotoxicity against HLA-E+ cells.
Mori KL; Furukawa H; Hayashi K; Sugimoto KJ; Oshimi K
Br J Haematol; 2003 Oct; 123(1):147-53. PubMed ID: 14510958
[TBL] [Abstract][Full Text] [Related]
40. The expression of killer cell inhibitory receptors on natural killer cells and activation status of CD4+ and CD8+ T cells in the decidua of normal and abnormal early pregnancies.
Chao KH; Wu MY; Chen CD; Yang JH; Yang YS; Ho HN
Hum Immunol; 1999 Sep; 60(9):791-7. PubMed ID: 10527385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
